Delivery Order SPE2DB22D1052-SPE2DB25FU9RB
Award Date 7/28/25
Potential Completion Date 8/18/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $12.78K delivery order to AmerisourceBergen Drug Corp for Attruby 356 mg tablets (28-count units) under a firm fixed-price contract. This non-set-aside award was issued on July 25, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,778.22, is a firm fixed-price delivery order for the supply of ATTRUBY 356 MG TABLET 28S medical products. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $12,778.22 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product, with a performance period ending on July 3, 2025. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4567968771 ATTRUBY 356 MG TABLET 28S, a medical product. The contract has a firm fixed price of $25,556.44 and a period of performance through May 9, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,778.22, is for the delivery of 4568039826 ATTRUBY 356 MG TABLET 28S. The contract is a firm fixed-price delivery order with a completion date of May 16, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a larger...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency within the Department of Defense. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $12,778.22 and with a completion date of June 27, 2025. The contract is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product. Amerisourcebergen Drug Corp is a for-profit organization...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,778.22 firm fixed-price contract is for the delivery of ATTRUBY 356 MG TABLET 28S, with an ultimate completion date of July 28, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, designated as SPE2DX, which provides a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,181.21 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be fulfilled from the contractor's Corporate Office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, awarded without set-aside provisions through competitive procurement, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contractor will perform the work at its corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...